Cutaneous and soft skin infections due to non-tuberculous mycobacteria

被引:22
作者
Alcaide, Fernando [1 ,2 ,4 ]
Esteban, Jaime [3 ,4 ]
机构
[1] Hosp Univ Bellvitge, IDIBELL, Microbiol Serv, Barcelona, Spain
[2] Univ Barcelona, Dept Patol & Terapeut Expt, Barcelona, Spain
[3] UTE, Fdn Jimenez Diaz, Dept Microbiol Clin, Madrid, Spain
[4] Soc Espanola Enfermedades Infecciosas & Microbiol, GEIM, Madrid, Spain
来源
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA | 2010年 / 28卷
关键词
Cutaneous mycobacteriosis; Rapidly growing mycobacteria; M; marinum; Buruli ulcer; ulcerans;
D O I
10.1016/S0213-005X(10)70008-2
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The frequency of isolation as well as the number of species of non-tuberculous mycobacteria (NTM) has increased in the last years. Nearly every pathogenic species of NTM may cause skin and soft tissue infections, but rapidly growing mycobacteria (Mycobacterium fortuitum, Mycobacterium chelonae and Mycobacterium abscessus), Mycobacterium marinum and Mycobacterium ulcerans are the most commonly involved. Many of these cutaneous mycobacteriosis, such as rapidly growing mycobacteria, M. marinum, Mycobacterium avium complex, Mycobacterium kansasii or Mycobacterium xenopi are world-wide distributed. In contrast, some others have a specific geographical distribution. This is the case of M. ulcerans, which causes a cutaneous diseases endemic of Central and West Africa (Buruli ulcer) and Australia (Bairnsdale ulcer), being the third mycobacterial infection after tuberculosis and leprosy. Cutaneous mycobacteriosis usually appear either after contact of traumatic or surgical wounds with water or other contaminated products, or, secondarily, as a consequence of a disseminated mycobacterial disease, especially among immunosuppressed patients. For an early diagnosis, it is necessary to maintain a high degree of suspicion in patients with chronic cutaneous diseases and a history of trauma, risk exposure and negative results of conventional microbiological studies. In general, individualized susceptibility testing is not recommended for most NTM infections, except for some species, and in case of therapeutic failure. Treatment includes a combination of different antimicrobial agents, but it must be taken into account that NTM are resistant to conventional antituberculous drugs. Severe cases or those with deep tissues involvement could also be tributary of surgical resection. (C) 2010 Elsevier Espana, Si All rights reserved.
引用
收藏
页码:46 / 50
页数:5
相关论文
共 44 条
  • [1] Alcaide F, 2006, ENFERM INFECC MIC S1, V24, pS53
  • [2] Alcaide F, 2008, TRATADO MED INTERNA, P2350
  • [3] Alcaide Fernandez de Vega F, 2016, SOC ESPANOLA ENFERME
  • [4] Soft tissue infections due to non-tuberculous mycobacteria following mesotherapy.: What is the price of beauty?
    Alejandra Rivera-Olivero, Ismar
    Guevara, Armando
    Escalona, Arnelly
    Oliver, Margarita
    Perez-Alfonzo, Ricardo
    Piquero, Jaime
    Zerpa, Olga
    de Waard, Jacobus H.
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2006, 24 (05): : 302 - 306
  • [5] Asiedu K, 2000, WHOCDSCPEGBUI20001
  • [6] Sixty-three cases of Mycobacterium marinum infection -: Clinical features, treatment, and antibiotic susceptibility of causative isolates
    Aubry, A
    Chosidow, O
    Caumes, E
    Robert, J
    Cambau, E
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (15) : 1746 - 1752
  • [7] Clinical patterns of cutaneous nontuberculous mycobacterial infections
    Bartralot, R
    García-Patos, V
    Sitjas, D
    Rodríguez-Cano, L
    Mollet, J
    Martín-Casabona, N
    Coll, P
    Castells, A
    Pujol, RM
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2005, 152 (04) : 727 - 734
  • [8] Susceptibilities of Mycobacterium marinum to gatifloxacin, gemifloxacin, levofloxacin, linezolid, moxifloxacin, telithromycin, and quinupristin-dalfopristin (Synercid) compared to its susceptibilities to reference macrolides and quinolones
    Bråbäck, M
    Riesbeck, K
    Forsgren, A
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (04) : 1114 - 1116
  • [9] CUTANEOUS MYCOBACTERIUM-KANSASII INFECTION - CASE-REPORT AND REVIEW
    BREATHNACH, A
    LEVELL, N
    MUNRO, C
    NATARAJAN, S
    PEDLER, S
    [J]. CLINICAL INFECTIOUS DISEASES, 1995, 20 (04) : 812 - 817
  • [10] Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria
    Brown-Elliott, BA
    Wallace, RJ
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 2002, 15 (04) : 716 - +